TABLE 2.

The risk estimate for the myocardial revascularization based on the TyG quartiles.

	Q1	Q2	Q3	Q4	P for trend
Total
Myocardial revascularization, n (%)	1,772 (53.5%)	2,044 (61.5%)	2,155 (65.0%)	2,230 (67.2%)
Model 1	Ref.	1.31 (1.18, 1.45)	1.57 (1.42, 1.74)	2.08 (1.87, 2.31)	<0.001
Model 2	Ref.	1.18 (1.05, 1.33)	1.30 (1.16, 1.47)	1.55 (1.37, 1.75)
Male
Myocardial revascularization, n (%)	1,281 (55.2%)	1,476 (62.1%)	1,513 (65.1%)	1,617 (66.8%)
Model 1	Ref.	1.25 (1.11, 1.41)	1.48 (1.31, 1.68)	1.90 (1.68, 2.15)	<0.001
Model 2	Ref.	1.12 (1.01, 1.28)	1.26 (1.10, 1.46)	1.45 (1.25, 1.68)
Female
Myocardial Revascularization, n (%)	491 (49.4%)	568 (60.0%)	642 (64.7%)	613 (68.4%)
Model 1	Ref.	1.48 (1.12,1.80)	1.81 (1.49, 2.20)	2.57 (2.09, 3.17)	<0.001
Model 2	Ref.	1.31 (1.05, 1.64)	1.37 (1.06, 1.68)	1.59 (1.23, 2.06)

Models 1: adjusted for age, gender.

Models 2: adjusted for age, gender, BMI, SBP, SUA, creatinine, HDL-C, TC, RBC, WBC, PLT, statin use, current smoker, current drinker, diabetes, and hypertension.

BMI, body mass index; HDL-C, high density lipoprotein cholesterol; PLT, platelets; RBC, red blood cell count; SBP, systolic blood pressure; SUA, serum uric acid; WBC, white blood cell count; TC, total cholesterol.